Cargando…
Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
Aim: To determine if supplementation of infants born <33 weeks’ gestation with higher dose docosahexaenoic acid (DHA) affects growth, body composition, and blood pressure at 7 y corrected age (CA) and if treatment effects differed by infant sex at birth and birth weight strata (<1250 and ≥1250...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867194/ https://www.ncbi.nlm.nih.gov/pubmed/36678206 http://dx.doi.org/10.3390/nu15020335 |
_version_ | 1784876281826902016 |
---|---|
author | Best, Karen P. Sullivan, Thomas R. Gunaratne, Anoja W. Gould, Jacqueline F. Gibson, Robert A. Collins, Carmel T. Makrides, Maria Green, Tim J. |
author_facet | Best, Karen P. Sullivan, Thomas R. Gunaratne, Anoja W. Gould, Jacqueline F. Gibson, Robert A. Collins, Carmel T. Makrides, Maria Green, Tim J. |
author_sort | Best, Karen P. |
collection | PubMed |
description | Aim: To determine if supplementation of infants born <33 weeks’ gestation with higher dose docosahexaenoic acid (DHA) affects growth, body composition, and blood pressure at 7 y corrected age (CA) and if treatment effects differed by infant sex at birth and birth weight strata (<1250 and ≥1250 g). Methods: Seven-year follow-up of an Australian multicenter randomized controlled trial in which 657 infants were fed high-DHA (≈1% total fatty acids) enteral feeds or standard-DHA (≈0.3% total fatty acids) from age 2–4 d until term CA. Seven-year CA outcomes were growth (weight, height), body composition (lean body mass, fat mass, waist, and hip circumference), and blood pressure. Results: There was no effect of high-DHA enteral feeds compared with standard-DHA on growth, body composition, and blood pressure at 7-year CA either overall or in subgroup analysis by sex. There was a significant interaction between high-DHA and birthweight strata on height at 7-y CA (p = 0.03). However, the post-hoc analyses by birthweight strata did not reach significance (p > 0.1). High-DHA group infants were more likely to be classified as obese (relative risk 1.6 (95% CI 1.0, 2.6); p = 0.05). Conclusions: DHA supplementation of premature infants did not affect growth, body composition, or blood pressure at 7-year CA overall by sex and birthweight strata. The finding of a higher risk of obesity in children who receive high-DHA needs to be interpreted with caution due to the small number of children classified as obese. |
format | Online Article Text |
id | pubmed-9867194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98671942023-01-22 Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial Best, Karen P. Sullivan, Thomas R. Gunaratne, Anoja W. Gould, Jacqueline F. Gibson, Robert A. Collins, Carmel T. Makrides, Maria Green, Tim J. Nutrients Article Aim: To determine if supplementation of infants born <33 weeks’ gestation with higher dose docosahexaenoic acid (DHA) affects growth, body composition, and blood pressure at 7 y corrected age (CA) and if treatment effects differed by infant sex at birth and birth weight strata (<1250 and ≥1250 g). Methods: Seven-year follow-up of an Australian multicenter randomized controlled trial in which 657 infants were fed high-DHA (≈1% total fatty acids) enteral feeds or standard-DHA (≈0.3% total fatty acids) from age 2–4 d until term CA. Seven-year CA outcomes were growth (weight, height), body composition (lean body mass, fat mass, waist, and hip circumference), and blood pressure. Results: There was no effect of high-DHA enteral feeds compared with standard-DHA on growth, body composition, and blood pressure at 7-year CA either overall or in subgroup analysis by sex. There was a significant interaction between high-DHA and birthweight strata on height at 7-y CA (p = 0.03). However, the post-hoc analyses by birthweight strata did not reach significance (p > 0.1). High-DHA group infants were more likely to be classified as obese (relative risk 1.6 (95% CI 1.0, 2.6); p = 0.05). Conclusions: DHA supplementation of premature infants did not affect growth, body composition, or blood pressure at 7-year CA overall by sex and birthweight strata. The finding of a higher risk of obesity in children who receive high-DHA needs to be interpreted with caution due to the small number of children classified as obese. MDPI 2023-01-10 /pmc/articles/PMC9867194/ /pubmed/36678206 http://dx.doi.org/10.3390/nu15020335 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Best, Karen P. Sullivan, Thomas R. Gunaratne, Anoja W. Gould, Jacqueline F. Gibson, Robert A. Collins, Carmel T. Makrides, Maria Green, Tim J. Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial |
title | Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial |
title_full | Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial |
title_fullStr | Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial |
title_full_unstemmed | Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial |
title_short | Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial |
title_sort | effect of docosahexaenoic acid (dha) supplementation of preterm infants on growth, body composition, and blood pressure at 7-years corrected age: follow-up of a randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867194/ https://www.ncbi.nlm.nih.gov/pubmed/36678206 http://dx.doi.org/10.3390/nu15020335 |
work_keys_str_mv | AT bestkarenp effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT sullivanthomasr effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT gunaratneanojaw effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT gouldjacquelinef effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT gibsonroberta effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT collinscarmelt effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT makridesmaria effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial AT greentimj effectofdocosahexaenoicaciddhasupplementationofpreterminfantsongrowthbodycompositionandbloodpressureat7yearscorrectedagefollowupofarandomizedcontrolledtrial |